Hidenobu Ishii Selected Research

Nivolumab

8/2018

The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidenobu Ishii Research Topics

Disease

25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2014
18	Neoplasms (Cancer) 10/2023 - 01/2014
9	Disease Progression 09/2023 - 09/2016
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 03/2015
5	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2016
4	Adenocarcinoma 11/2021 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
3	Adenocarcinoma of Lung 11/2021 - 10/2015
2	Diarrhea 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 11/2018
2	Inflammation (Inflammations) 11/2018 - 11/2009
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2023
1	Thymic epithelial tumor 03/2023
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Stomatitis 01/2020
1	Erythema Multiforme 01/2020
1	Anorexia 01/2020
1	Paronychia 01/2020
1	Infections 11/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2018
1	Febrile Neutropenia 11/2018
1	Dehydration (Water Stress) 11/2018
1	Fever (Fevers) 11/2018
1	Heart Failure 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Myocarditis (Carditis) 11/2018
1	Neutropenia 11/2018
1	Respiratory Insufficiency (Respiratory Failure) 11/2018
1	Septic Shock (Toxic Shock Syndrome) 11/2018
1	Colitis 08/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2017
1	Pancytopenia 10/2017
1	Abdominal Pain (Pain, Abdominal) 10/2015
1	Ulcerative Colitis 10/2015
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015
1	Lymphoma (Lymphomas) 05/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Asthma (Bronchial Asthma) 11/2009

Drug/Important Bio-Agent (IBA)

8	PlatinumIBA 01/2023 - 09/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2018
5	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2015
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
4	AfatinibIBA 01/2023 - 01/2018
4	LigandsIBA 01/2023 - 03/2015
4	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 12/2018
4	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2015
3	osimertinibIBA 01/2023 - 01/2020
3	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2018
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 12/2014
3	Pemetrexed (MTA)FDA Link 06/2018 - 10/2015
2	durvalumabIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2023 - 10/2015
2	atezolizumabIBA 01/2023 - 01/2021
2	avelumabIBA 01/2021 - 11/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2019 - 05/2015
2	Cell-Free Nucleic AcidsIBA 01/2019 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 10/2015
1	Contrast MediaIBA 03/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Extracellular Matrix ProteinsIBA 11/2021
1	PeriostinIBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Keratins (Keratin)IBA 05/2019
1	Carcinoembryonic AntigenIBA 05/2019
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	AntibodiesIBA 11/2018
1	Immune Checkpoint ProteinsIBA 11/2018
1	Lipase (Acid Lipase)FDA Link 11/2018
1	NivolumabIBA 08/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	Caspase 3 (Caspase-3)IBA 10/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2015
1	Anaplastic Lymphoma KinaseIBA 05/2015
1	GoldIBA 04/2015
1	Programmed Cell Death 1 ReceptorIBA 03/2015
1	Bronchodilator Agents (Bronchodilators)IBA 11/2009

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 10/2023 - 10/2015
8	Aftercare (After-Treatment) 01/2021 - 10/2015
6	Therapeutics 01/2022 - 11/2009
1	Proton Therapy 10/2023
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 09/2017
1	Bronchoscopes 01/2017
1	Duration of Therapy 11/2016
1	Chemoradiotherapy 03/2016
1	Colectomy 10/2015
1	Pancreaticoduodenectomy 01/2014
1	Lymph Node Excision (Lymph Node Dissection) 01/2014